The HIV antiretroviral drug efavirenz has LSD-like properties
about
Efavirenz and the CNS: what we already know and questions that need to be answeredThe dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites.Substance use in older HIV-infected patients.Efavirenz modulation of sleep spindles and sleep spectral profile.Neuropsychiatric Effects of HIV Antiviral Medications.Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVWhoonga: potential recreational use of HIV antiretroviral medication in South Africa.Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.Safety Evaluation of Efavirenz in Children: Don't Forget the Central Nervous System.HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation in Vitro and in Vivo.Efavirenz is related to neuropsychiatric symptoms among adults, but not among adolescents living with human immunodeficiency virus in Kilimanjaro, Tanzania.Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins.The Rise and Fall of Efavirenz.Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats
P2860
Q28085028-AEBE0DD6-923A-4D3C-B958-219E98746ACDQ30401509-6643D57D-6AD4-48E6-852B-AA1626D397EEQ34247817-9E7692AF-EAAD-46C8-B284-FC091F511692Q34433247-7B01AE9C-E886-4C7A-A0A6-E57D3CFE801CQ34537705-431AF1DD-15BD-4A05-A3D4-586B5FAC6485Q36937565-6A6B9057-53C9-4091-BFC1-F0D8206F96CDQ37589276-526056B0-F3C5-4D1E-93CF-E71FDFDFF8BEQ39503882-6145D722-CADE-4034-A407-1CEF91D14180Q40458433-7B7F1254-1E92-430B-BC2A-CA4B3C6E350AQ42592784-A2E98007-2F03-4179-8DDD-DCC42F674281Q43924133-FE562FEE-0132-4FA8-8AE8-1ACF61367ACBQ47107359-8A4B6826-9EB7-4429-8BC0-666B37FC2A03Q47567926-34E15747-0845-4040-B0A2-88E0326B0512Q47895958-37B0EA63-3EFB-4F82-A63D-8CCD2C719221Q54665423-1FEBF73B-C1B5-40BF-977C-1863FA87DA7AQ58701199-BEDD3F0C-87C5-4334-9C81-549324F3FC0F
P2860
The HIV antiretroviral drug efavirenz has LSD-like properties
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The HIV antiretroviral drug efavirenz has LSD-like properties
@ast
The HIV antiretroviral drug efavirenz has LSD-like properties
@en
The HIV antiretroviral drug efavirenz has LSD-like properties
@nl
type
label
The HIV antiretroviral drug efavirenz has LSD-like properties
@ast
The HIV antiretroviral drug efavirenz has LSD-like properties
@en
The HIV antiretroviral drug efavirenz has LSD-like properties
@nl
prefLabel
The HIV antiretroviral drug efavirenz has LSD-like properties
@ast
The HIV antiretroviral drug efavirenz has LSD-like properties
@en
The HIV antiretroviral drug efavirenz has LSD-like properties
@nl
P2093
P2860
P3181
P356
P1476
The HIV antiretroviral drug efavirenz has LSD-like properties
@en
P2093
Alexey Kozlenkov
Charles P France
Glenn H Dillon
Jacques D Nguyen
Javier González-Maeso
John A Schetz
Kenner C Rice
Michael B Gatch
Michael J Forster
Ren-Qi Huang
P2860
P2888
P304
P3181
P356
10.1038/NPP.2013.135
P407
P577
2013-11-01T00:00:00Z
P5875
P6179
1044235835